Multi-disciplinary program shows promise for treating ADHD, post-concussion syndrome, and memory loss

FHS
June 30, 2023
5:33 pm

The Journal of Alzheimer’s Disease Reports published a paper today by nationally-recognized neurologist Dr. Majid Fotuhi, MD, PhD that details a multi-disciplinary program for patients with Attention Deficit Hyperactive Disorder (ADHD), post-concussion syndrome (PCS), or memory loss.

EU pharma legislation may bring ‘more harm than good’ to the region

Reform of the EU pharmaceutical legislation was launched in April by the European Commission. Credit: New Africa via Shutterstock. Debates across Europe are needed to

November 7, 2023

Study offers insights into chronic fatigue syndrome and its resemblance to long COVID-19

The study, which will serve “as a guide for rapid diagnosis”, provides valuable information for the medical community, in particular in primary care.

September 20, 2024

Organigram Buys Canadian LP Motif for C$90 Million

Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share December 06, 2024 Transformational Acquisition Results in Cannabis Pure Play Leader, Coast-to-Coast Geographic Strength

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.